
Phil Rivers Tech Raises Eight-Figure Series A1 to Advance AI4S-Driven Drug Innovation
Phil Rivers Tech has raised an eight-figure Series A1 round to accelerate AI4S-powered drug discovery and push multiple innovative therapies into clinical development.











